Wenk, 2005 - Google Patents
The emerging field of lipidomicsWenk, 2005
- Document ID
- 4309169569538715503
- Author
- Wenk M
- Publication year
- Publication venue
- Nature reviews Drug discovery
External Links
Snippet
The crucial role of lipids in cell, tissue and organ physiology is demonstrated by a large number of genetic studies and by many human diseases that involve the disruption of lipid metabolic enzymes and pathways. Examples of such diseases include cancer, diabetes, as …
- 150000002632 lipids 0 abstract description 247
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
- G01N2405/04—Phospholipids, i.e. phosphoglycerides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P-C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P-C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wenk | The emerging field of lipidomics | |
Han et al. | The foundations and development of lipidomics | |
Bou Khalil et al. | Lipidomics era: accomplishments and challenges | |
Takeda et al. | Widely-targeted quantitative lipidomics method by supercritical fluid chromatography triple quadrupole mass spectrometry [S] | |
Wang et al. | Novel advances in shotgun lipidomics for biology and medicine | |
Rolim et al. | Lipidomics in the study of lipid metabolism: Current perspectives in the omic sciences | |
Han et al. | Shotgun lipidomics of phosphoethanolamine-containing lipids in biological samples after one-step in situ derivatization | |
Han et al. | Toward fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry | |
Wolf et al. | Lipidomics: Practical aspects and applications | |
Lam et al. | Lipidomics as a principal tool for advancing biomedical research | |
Cífková et al. | Nontargeted quantitation of lipid classes using hydrophilic interaction liquid chromatography–electrospray ionization mass spectrometry with single internal standard and response factor approach | |
Zemski Berry et al. | MALDI imaging of lipid biochemistry in tissues by mass spectrometry | |
Fernandis et al. | Lipid-based biomarkers for cancer | |
Bird et al. | Lipidomics profiling by high-resolution LC− MS and high-energy collisional dissociation fragmentation: Focus on characterization of mitochondrial cardiolipins and monolysocardiolipins | |
Castro-Perez et al. | Comprehensive LC− MSE lipidomic analysis using a shotgun approach and its application to biomarker detection and identification in osteoarthritis patients | |
Lam et al. | High-coverage lipidomics for functional lipid and pathway analyses | |
Loizides‐Mangold | On the future of mass‐spectrometry‐based lipidomics | |
Hu et al. | Recognition and avoidance OF ION source‐generated artifacts IN lipidomics analysis | |
Witting et al. | The Caenorhabditis elegans lipidome: A primer for lipid analysis in Caenorhabditis elegans | |
Forest et al. | Comprehensive and reproducible untargeted lipidomic workflow using LC-QTOF validated for human plasma analysis | |
Li et al. | Stable isotope-assisted lipidomics combined with nontargeted isotopomer filtering, a tool to unravel the complex dynamics of lipid metabolism | |
CN112739441A (en) | Systems and methods for lipid quantification | |
Zhang et al. | Improving lipidomic coverage using UPLC-ESI-Q-TOF-MS for marine shellfish by optimizing the mobile phase and resuspension solvents | |
Pan et al. | Lipid metabolism and lipidomics applications in cancer research | |
Ekroos | Lipidomics perspective: from molecular lipidomics to validated clinical diagnostics |